2022
Contrast-induced acute kidney injury and its contemporary prevention
SŮVA, Marek, Petr KALA, Martin POLOCZEK, Jan KAŇOVSKÝ, Roman ŠTÍPAL et. al.Základní údaje
Originální název
Contrast-induced acute kidney injury and its contemporary prevention
Autoři
SŮVA, Marek (203 Česká republika, domácí), Petr KALA (203 Česká republika, garant, domácí), Martin POLOCZEK (203 Česká republika, domácí), Jan KAŇOVSKÝ (203 Česká republika, domácí), Roman ŠTÍPAL (203 Česká republika, domácí), Martin RADVAN (203 Česká republika, domácí), Jiří HLÁSENSKÝ (203 Česká republika, domácí), Martin HUDEC (203 Česká republika, domácí), Vojtěch BRÁZDIL (203 Česká republika, domácí) a Jitka ŘEHOŘOVÁ (203 Česká republika)
Vydání
Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2022, 2297-055X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.600
Kód RIV
RIV/00216224:14110/22:00128215
Organizační jednotka
Lékařská fakulta
UT WoS
000899788400001
Klíčová slova anglicky
PCI; nephrotoxicity; acute kidney injury; contrast-induced acute kidney injury; chronic renal insufficiency; prevention
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 23. 1. 2023 10:38, Mgr. Tereza Miškechová
Anotace
V originále
The complexity and application range of interventional and diagnostic procedures using contrast media (CM) have recently increased. This allows more patients to undergo procedures that involve CM administration. However, the intrinsic CM toxicity leads to the risk of contrast-induced acute kidney injury (CI-AKI). At present, effective therapy of CI-AKI is rather limited. Effective prevention of CI-AKI therefore becomes crucially important. This review presents an in-depth discussion of CI-AKI incidence, pathogenesis, risk prediction, current preventive strategies, and novel treatment possibilities. The review also discusses the difference between CI-AKI incidence following intraarterial and intravenous CM administration. Factors contributing to the development of CI-AKI are considered in conjunction with the mechanism of acute kidney damage. The need for ultimate risk estimation and the prediction of CI-AKI is stressed. Possibilities of CI-AKI prevention is evaluated within the spectrum of existing preventive measures aimed at reducing kidney injury. In particular, the review discusses intravenous hydration regimes and pre-treatment with statins and N-acetylcysteine. The review further focuses on emerging alternative imaging technologies, alternative intravascular diagnostic and interventional procedures, and new methods for intravenous hydration guidance; it discusses the applicability of those techniques in complex procedures and their feasibility in current practise. We put emphasis on contemporary interventional cardiology imaging methods, with a brief discussion of CI-AKI in non-vascular and non-cardiologic imaging and interventional studies.